New York Section. President, Polish Urological Association. Krakow, Poland October 4-8, Joint Meeting 1 st Polish American Urologic Congress

Size: px
Start display at page:

Download "New York Section. President, Polish Urological Association. Krakow, Poland October 4-8, 2010. Joint Meeting 1 st Polish American Urologic Congress"

Transcription

1 New York Section American Urological Association 108 th Annual Meeting Krakow, Poland October 4-8, 2010 Joint Meeting 1 st Polish American Urologic Congress President, New York Section, AUA Chairman of Urology, Jagiellonian University President, American Urological Association President, Polish Urological Association Ihor S. Sawczuk, M.D. Zygmunt Dobrowolski, M.D. Datta G. Wagle, M.D. Marek Sosnowski, M.D. Scientific Chairmen Ravi Munver, M.D. James McKiernan M.D. Visiting Professors Gopal Badlani, M.D. Leonard Gomella, M.D. Michael Manyak, M.D. Rolf Ackermann, M.D. John Fitzpatrick, M.D. 1 8/13/2010

2 MONDAY, OCTOBER 4 TH 2010 INTRODUCTIONS 7:00-7:15 am Ihor Sawczuk: Welcome from President, New York Section, American Urological Association Zygmunt Dobrowolski: Welcome from Chairman of Urology, Jagiellonian University Datta Wagle: Welcome from President, American Urological Association Marek Sosnowski: Welcome from President, Polish Urological Association SESSION I: BLADDER CANCER Michael Droller, Zygmunt Dobrowolski 7:15-7:25 am Mitchell Benson: State of the art: Update on bladder cancer 7:25-7:35 am Michael Droller: The value of urinary markers in screening and monitoring of bladder cancer 7:35-7:45 am Zbigniew Jabłonowski: Quantitative analysis of P-16 and DAPK promoter methylation in patients with non-invasive urothelial cancer 7:45-7:55 am Zygmunt Dobrowolski: Photodynamic diagnosis of bladder cancer 7:55-8:05 am Muhammad Choudhury: Diagnosis and management of non-muscle invasive bladder cancer 8:05-8:15 am James McKiernan: Novel intravesical therapies for superficial bladder cancer 8:15-8:25 am Muhammad Choudhury: Radiation induced secondary bladder cancer: Fact or myth 8:25-8:35 am E. Darracott Vaughan: Radical retropubic cystectomy 8:35-8:45 am Piotr Chłosta: Laparoscopic cystectomy 8:45-8:55 am Bernard Bochner: Contemporary outcomes following radical cystectomy: Prognostic tools and complications 8:55-9:05 am Robert Weiss: Update on urinary diversions 9:05-9:15 am Bernard Bochner: Current status of perioperative chemotherapy for locally advanced invasive bladder cancer 9:15-9:25 am Daniel Petrylak: Targeted therapy for metastatic bladder cancer 9:25-9:40 am Panel: Benson, Bochner, Chłosta, Choudhury, Dobrowolski, Droller, Jabłonowski, McKiernan, Petrylak, Vaughan, Weiss 9:40-10:00 am **************************BREAK************************** SESSION II: BENIGN PROSTATIC HYPERPLASIA Nicholas Romas, Zygmunt Dobrowolski 10:00-10:10 am Steven Kaplan: Medical management of BPH What s new? 10:10-10:20 am Jaspreet Sandhu: The current state of laser prostatectomy: 2010 Update 10:20-10:30 am Stanisław Stępień: Learning curve of Tm LEP enucleation 10:30-10:40 am Tomasz Maliszewski: Diode laser 980 nm BPH vaporization and vaporesection: Technique and results 10:40-10:50 am Ivan Grunberger: A novel technique for benign prostate tissue ablation The plasma vaporization electrode 10:50-11:00 am Tomasz Borkowski: Laparoscopic adenomectomy 11:00-11:15 am Panel: Borkowski, Grunberger, Kaplan, Maliszewski, Sandhu, Stępień SESSION III: ADRENAL TUMORS / PENILE CANCER Pramod Sogani, Marek Sosnowski 11:15-11:25 am Pramod Sogani: Evaluation and management of malignant adrenal masses 11:25-11:35 am Ravi Munver: Laparoscopic and robotic partial adrenalectomy 11:35-11:45 am Tomasz Demkow: Predictive factors for the presence of lymph node metastases in modified inguinal lymphadenectomy in penile cancer patients 11:45-12:00 pm Panel: Demkow, Munver, Sogani 2 8/13/2010

3 TUESDAY, OCTOBER 5 TH, 2010 SESSION IV: WOMEN S HEALTH Steven Kaplan, Piotr Radziszewski 7:00-7:20 am Gopal Badlani State of the art: Pelvic floor reconstruction techniques 7:20-7:30 am Elizabeth Kavaler: Controversies in female urology and pelvic floor reconstruction 7:30-7:40 am Yitzhak Berger: Surgical outcomes of sling surgery in women with mixed urinary incontinence 7:40-7:50 am Debra Fromer: Management of midurethral sling complications 7:50-8:00 am Piotr Radziszewski: Shaping of lower urinary tract innervation with neurotoxins. 8:00-8:10 am Jonathan Vapnek: Review of neurogenic bladder Principles and practice 8:10-8:20 am Elizabeth Kavaler: Female sexual dysfunction: Where are we now and where are we going? 820-8:35 am Panel: Badlani, Berger, Fromer, Kavaler, Radziszewski, Vapnek SESSION V: KIDNEY I Paul Russo, Tomasz Demkow 8:35-8:45 am Mark Jordan: Urologic malignancies in renal transplant patients 8:45-8:55 am James McKiernan: Update on 2010 AJCC/UICC staging system for kidney cancer 8:55-9:05 am Paul Russo: Medical and oncologic rationale for partial nephrectomy for the treatment of small renal masses 9:05-9:15 am Marcin Słojewski: Laparoscopic partial nephrectomy: The quicker the better? 9:15-9:25 am Lesław Świebocki: Treatment of renal cell carcinoma with vena cava involvement 9:25-9:35 am Krzysztof Krzemieniecki: Review of systemic therapy of kidney cancer Louis Kavoussi: Preservation of renal function: Off-clamp laparoscopic partial nephrectomy 9:35-9:50 am Panel: Jordan, Kavoussi, Krzemieniecki, McKiernan, Russo, Słojewski, Sokołowski 9:50-10:10 am **************************BREAK************************** SESSION VI: MEN S HEALTH Ivan Grunberger, Andrzej Sikorski 10:10-10:20 am Harry Fisch: The male biological clock 10:20-10:30 am Frank Lowe: Review of genital manifestations of medical diseases 10:30-10:40 am Harris Nagler: Effects of treatment of urologic disorders on fertility 10:40-10:50 am David Shin: Vasectomy: Past, present, future. 10:50-11:00 am Harris Nagler: Modern management of infertility 11:00-11:10 am David Shin: Scientific rationale for penile rehabilitation after pelvic surgery 11:10-11:20 am Steven Kaplan: Complementary medicine in prostate health 11:20-11:30 am Frank Lowe: What I tell my patients about vitamins and supplement usage 11:30-11:50 am Leonard Gomella: Prostate cancer and male osteoporosis 11:50-12:05 pm Panel: Fisch, Gomella, Kaplan, Lowe, Nagler, Shin American Urological Association - President Lecture 12:05-12:25 pm Datta Wagle: Health care issues facing us 3 8/13/2010

4 WEDNESDAY, OCTOBER 6 TH, 2010 SESSION VII: ROBOTIC SURGERY Ash Tewari, Tomasz Borkowski 7:00-7:10 am Arieh Shalhav: Robotic radical prostatectomy To do it or not? 7:10-7:20 am Ravi Munver: Robotic partial nephrectomy Update and advancements 7:20-7:30 am Ketan Badani: Robotic pyeloplasty and upper tract reconstruction Outcomes and future 7:30-7:40 am Robert Weiss: Robotic cystectomy Is it ready for prime time? 7:40-7:50 am Gregory Lovallo: Robotic sacrocolpopexy Technique and results 7:50-8:05 am Panel: Badani, Lovallo, Munver, Shalhav, Weiss SESSION VIII: PROSTATE CANCER I Carl Olsson, Andrzej Borkowski 8:05-8:25 am Datta Wagle: American Urological Association policy regarding PSA 8:25-8:35 am E. Darracott Vaughan: PSA: To screen or not to screen? That is the question 8:35-8:45 am Maciej Salagierski: Identification of ETS gene fusion using Affymetrix exon 1.0 ST array in noninvasive detection of prostate cancer 8:45-8:55 am Wacław Lipczyński: Improving effectiveness of targeted transrectal core biopsy based on magnetic resonance spectroscopy imaging 8:55-9:05 am Frederick Gulmi: Transrectal prostate biopsy and antibiotic resistance 9:05-9:15 am Andrzej Urbanik: Applications of magnetic resonance imaging in the evaluation of prostate cancer 9:15-9:35 am Leonard Gomella: Chemoprevention for prostate cancer 9:35-9:55 am Michael Manyak: Molecular risk predication of prostate cancer 9:55-10:10 am Panel: Gomella, Gulmi, Lipczyński, Manyak Salagierski, Urbanik, Vaughan, Wagle Management of rising PSA: After radical prostatectomy After radiotherapy After cryotherapy/hifu 10:10-10:30 am **************************BREAK************************** SESSION IX: PROSTATE CANCER II Robert Waldbaum, Marek Wyczółkowski 10:30-10:40 am John Fitzpatrick: Management of localized prostate cancer in senior adults 10:40-10:50 am Michael Palese: Cryoablation of the prostate: Total vs. focal therapy 10:50-11:00 am James Eastham: Radical prostatectomy in high risk clinically localized prostate cancer 11:00-11:10 am Mitchell Benson: Multimodality therapy for high risk localized prostate cancer 11:10-11:20 am James Eastham: Management of radiation recurrent prostate cancer 11:20-11:40 am Michael Manyak: The search for prostate cancer: Molecular functional imaging 11:40-11:50 am Daniel Petrylak: New approaches to the treatment of castration resistant prostate cancer 11:50-12:05 pm Panel: Benson, Eastham, Fitzpatrick, Manyak, Palese, Petrylak 4 8/13/2010

5 THURSDAY, OCTOBER 7 TH, 2010 SESSION X: UROLITHIASIS / ENDOUROLOGY Majid Eshghi, Waldemar Różański 7:30-7:40 am Majid Eshghi: Management of lower pole stones 7:40-7:50 am R. Ernest Sosa Stone management in obese patients 7:50-8:00 am Małgorzata Bąk: Comparing pathophysiological effects of lithoclast versus Holmium laser lithotripsy for ureteral stones 8:00-8:10 am Mantu Gupta: PCNL: Tube or no tube? That is the question 8:10-8:20 am Ryszard Herbeć: Complications of PCNL 8:20-8:30 am Majid Eshghi: Update on endoscopic treatment of upper tract urothelial carcinoma 8:30-8:40 am Mantu Gupta: Endourological management of upper tract urothelial carcinoma: Tips and tricks 8:40-8:55 am Panel: Bąk, Eshghi, Gupta, Herbeć, Sosa SESSION XI: VOIDING DYSFUNCTION Felix Badillo, Zbigniew Wolski 8:55-9:15 am Gopal Badlani: Management of voiding dysfunction after GU therapy 9:15-9:25 am Jaspreet Sandhu: Managing post-prostate radiation voiding dysfunction 9:25-9:35 am Tomasz Szopiński: Artificial urinary sphincters 9:35-9:45 am Jonathan Vapnek: Intravesical Botulinum (Botox) 2010 Update 9:45-10:00 am Panel: Badlani, Sandhu, Szopiński, Vapnek 10:00-10:20 am **************************BREAK************************** SESSION XII: KIDNEY II Mark Jordan, Joachim Thuroff 10:20-10:30 am Lee Richstone: Laparoscopic innovations: Instruments and techniques 10:30-10:40 am Mark Jordan: Minimally invasive techniques applied to transplantation 10:40-10:50 am Joachim Thuroff: Are small renal tumors insignificant? Correlation of clinical and pathohistological features with tumor size 10:50-11:00 am Marcin Słojewski: Laparoscopic management of parenchymal renal tumors: Retroperitoneal approach 11:00-11:10 am Michael Palese: Ablative treatment of the small renal mass: Cryoablation and RFA 11:10-11:20 am Arieh Shalhav: Partial nephrectomy outcomes: Open, laparoscopic, robotic, and LESS 11:20-11:30 am Zygmunt Dobrowolski: Renal cell cancer with atrial involvement 11:30-11:40 am Paul Russo: Targeted imaging for renal cell carcinoma 11:40-11:50 am Daniel Petrylak: Targeted therapy for renal cell carcinoma 11:50-12:05 pm Panel: Dobrowolski, Jordan, Palese, Petrylak, Richstone, Russo, Shalhav, Słojewski, Thuroff American Urological Association - Foundation Lecture 12:05-12:15 am Robert Waldbaum: Update on the status of the American Urological Association Foundation 5 8/13/2010

6 FRIDAY, OCTOBER 8 TH, 2010 SESSION XIII: PROSTATE CANCER III Muhammad Choudhury, Romuald Zdrojowy 7:30-7:40 am Ash Tewari: Anatomical studies of tissue planes during minimally invasive prostatectomy 7:40-7:50 am James Eastham: Reassessing the boundaries of PLND in prostate cancer 7:50-8:00 am Ketan Badani: Evidence-based outcomes: Robotic vs. open radical prostatectomy 8:00-8:10 am Ash Tewari: Macroanatomy of the pelvis as it relates to continence and potency: Lessons learned from robotic radical prostatectomy 8:10-8:20 am Robert Waldbaum: Brachytherapy for localized prostate cancer: A review 8:20-8:30 am Glen Gejerman: State of the art: Brachytherapy plus external beam radiation therapy for intermediate/high risk disease: Rationale, toxicity, efficacy, and future role 8:30-8:40 am Piotr Milecki Comparison of hormone therapy alone with hormone therapy combined with radiotherapy in the treatment of high risk prostate cancer patients 8:40-8:50 am Carl Olsson: Ownership of radiation treatment centers and urologists use of radiotherapy 8:50-9:05 am Panel: Badani, Eastham, Gejerman, Milecki, Olsson, Tewari, Waldbaum Optimizing outcomes of prostate cancer therapy: Radical prostatectomy Radiation therapy 9:05-9:25 am **************************BREAK************************** SESSION XIV: NEW TECHNOLOGIES AND MISCELLANEOUS TOPICS IN UROLOGY Rolf Ackermann 9:25-9:35 am R. Ernest Sosa: Use of ultrasound in office practice 9:35-9:45 am Ivan Grunberger: HIFU: Prostate cancer 9:55-10:05 am Glen Gejerman: New technologies in image-guided radiation therapy: Tools to see, track and hit the prostate gland 10:05-10:15 am Lee Richstone: LESS in urology: Progress or chicanery? 10:15-10:25 am Wiesław Urbanowicz: Laparoscopic vaginal reconstruction using an isolated sigmoid segment 10:25-10:35 am Tomasz Drewa: Heterotopic stem cells for experimental urinary bladder regeneration 10:35-10:45 am Agha Babanoury: History of Persian urology 10:45-11:05 am Michael Manyak: Expedition medicine: From the Poles to the jungle 11:05-11:20 am Panel: Babanoury, Drewa, Gejerman, Grunberger, Manyak, Richstone, Salagierski, Sosa, Urbanowicz CLOSING COMMENTS: 11:20-11:25 am R. Ernest Sosa: President-Elect, New York Section, American Urological Association 11:25-11:30 am Zygmunt Dobrowolski: Chairman of Urology, Jagiellonian University 11:30-11:35 am Ihor Sawczuk: President, New York Section, American Urological Association 6 8/13/2010

7 FACULTY United States Faculty Agha Babanoury, M.D. Felix Badillo, M.D. Gopal Badlani, M.D. Ketan Badani, M.D. Mitchell Benson, M.D. Yitzhak Berger, M.D. Bernard Bochner, M.D. Muhammad Choudhury, M.D. Michael Droller, M.D. James Eastham, M.D. Majid Eshghi, M.D. Harry Fisch, M.D. Debra Fromer, M.D. Glen Gejerman, M.D. Leonard Gomella, M.D. Ivan Grunberger, M.D. Frederick Gulmi, M.D. Mantu Gupta, M.D. Mark Jordan, M.D. Steven Kaplan, M.D. Elizabeth Kavaler, M.D. Louis Kavoussi, M.D. Franklin Lowe, M.D. Gregory Lovallo, M.D. Michael Manyak, M.D. James McKiernan, M.D. Ravi Munver, M.D. Harris Nagler, M.D. Carl Olsson, M.D. George Owens, M.D. Michael Palese, M.D. Daniel Petrylak, M.D. Lee Richstone, M.D. Nicholas Romas, M.D. Paul Russo, M.D. Jaspreet Sandhu, M.D. Ihor Sawczuk, M.D. Arieh Shalhav, M.D. David Shin, M.D. Pramod Sogani, M.D. R. Ernest Sosa, M.D. Ashutosh Tewari, M.D. Jonathan Vapnek, M.D. E. Darracott Vaughan, M.D. Datta Wagle, M.D. Robert Waldbaum, M.D. Robert Weiss, M.D. 7 8/13/2010

8 Poland Faculty Małgorzata Bąk Andrzej Borkowski Tomasz Borkowski Piotr Chłosta Tomasz Demkow Tomasz Drewa Wojciech Habrat Ryszard Herbeć Zygmunt Dobrowolski Zbigniew Jabłonowski Kazimierz Krajka Krzysztof Krzemieniecki Wacław Lipczyński Tomasz Maliszewski Piotr Milecki Piotr Radziszewski Waldemar Różański Maciej Salagierski Andrzej Sikorski Marcin Słojewski Jerzy Sokołowski Marek Sosnowski Stanisław Stępień Tomasz Szopinski Andrzej Urbanik Wiesław Urbanowicz Zbigniew Wolski Romuald Zdrojowy International Faculty Rolf Ackermann John Fitzpatrick Joachim Thuroff 8 8/13/2010

Prostate Cancer. Treatments as unique as you are

Prostate Cancer. Treatments as unique as you are Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential

More information

2016 Mayo Clinic Urology Review

2016 Mayo Clinic Urology Review 2016 Mayo Clinic Urology Review Please note that all times and speakers are subject to change. All sessions located in Grand Ballroom 2-5 unless otherwise noted. MONDAY, JANUARY 25, 2016 6:00 a.m. - 11:00

More information

Prostate Cancer Treatment: What s Best for You?

Prostate Cancer Treatment: What s Best for You? Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.

More information

7. Prostate cancer in PSA relapse

7. Prostate cancer in PSA relapse 7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined

More information

Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology

Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology Prostate Cancer Epidemiology: 2009 Estimated new cases: 230,000 Estimated deaths:

More information

East Lancashire Surgical Robot

East Lancashire Surgical Robot East Lancashire Surgical Robot For ALL patients in Lancashire Prostate cancer claims the life of one man every hour and by 2030 will be the most common cancer; it is already the most common male cancer.

More information

da Vinci Prostatectomy (Robotically Assisted Radical Prostatectomy)

da Vinci Prostatectomy (Robotically Assisted Radical Prostatectomy) Peninsula Urology Center, Inc. Dieter Bruno, M.D, F.A.C.S Chris Threat, M.D. 3351 El Camino. Real, Suite 101 Atherton, CA 94027 (650) 306-1016 dbrunomd@pucenter.com http://www.pucenter.com/ da Vinci Prostatectomy

More information

Combined Harvard Urologic Oncology Fellowship Program

Combined Harvard Urologic Oncology Fellowship Program Combined Harvard Urologic Oncology Fellowship Program 1 Goal: Department of Urology To reduce the disease burden for patients with urologic issues by improving: Clinical Care Teaching Research 2 History

More information

Advances in Prostate Imaging and Ablative Treatment of Prostate Cancer

Advances in Prostate Imaging and Ablative Treatment of Prostate Cancer Provided by the NYU Post-Graduate Medical School Advances in Prostate Imaging and Ablative Treatment of Prostate Cancer Friday Saturday June 19 20, 2015 New York City Register online: med.nyu.edu/cme/mi

More information

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

Beyond the PSA: Genomic Testing in Localized Prostate Cancer Beyond the PSA: Genomic Testing in Localized Prostate Cancer Kelvin A. Moses, MD, PhD Vanderbilt University Medical Center Wednesday, December 2, 2015 5:00 p.m. ET/2:00 p.m. PT About ZERO ZERO s mission

More information

Management of Localized Prostate Cancer. Treatment Options

Management of Localized Prostate Cancer. Treatment Options Management of Localized Prostate Cancer Surgery James A. Eastham, MD Chief, Urology Service Memorial lsloan Kettering Cancer Center Treatment Options 1. Active surveillance/watchful waiting 2. Focal therapy

More information

Early Prostate Cancer: Questions and Answers. Key Points

Early Prostate Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:

More information

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma. Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of

More information

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

Thomas A. Kollmorgen, M.D. Oregon Urology Institute Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men

More information

PSA Screening for Prostate Cancer Information for Care Providers

PSA Screening for Prostate Cancer Information for Care Providers All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits

More information

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent

More information

The prostate and kidney cancer specialists. Robot-assisted surgery for prostate and kidney cancer

The prostate and kidney cancer specialists. Robot-assisted surgery for prostate and kidney cancer The prostate and kidney cancer specialists Robot-assisted surgery for prostate and kidney cancer ROBOT-ASSISTED SURGERY AT HARLEY STREET UROLOGY Mr Marc Laniado, Consultant Urologist Robot-assisted prostatectomy,

More information

Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke

Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis

More information

855-DRSAMADI or 212-241-8779

855-DRSAMADI or 212-241-8779 SMART SURGERY NEWS MARCH 2013 Dr. David Samadi 855-DRSAMADI or 212-241-8779 YOUR PROSTATE CANCER NEWS PREVENTION DIAGNOSIS TREATMENT LIFE AFTER PROSTATE CANCER PREVENTION Prostate Cancer Need-to-Knows

More information

Quality of Life After Radical Prostatectomy

Quality of Life After Radical Prostatectomy Quality of Life After Radical Prostatectomy Bernard H. Bochner, MD FACS Attending Surgeon, Urology Service Vice Chairman, Department of Surgery Memorial Sloan-Kettering Cancer Center Quality of Life After

More information

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj. PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition weiss@umdnj.edu September 23, 2010 Screening: 3 tests for PCa A good screening

More information

Rotolo, Howard & Leitner Urologic Associates

Rotolo, Howard & Leitner Urologic Associates Visit us now online at www.njphysician.org JULY 2012 JULY 2012 Rotolo, Howard & Leitner Urologic Associates The Physicians of This Innovative Practice Speak Out on the PSA Screening Controversy and Other

More information

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options INTRODUCTION This booklet describes how prostate cancer develops, how it affects the body and the current treatment methods. Although

More information

Contact Maryann Verrillo Diane Shnitzler (703) 691-1805. Interventional Radiology Treatments for Kidney Cancer

Contact Maryann Verrillo Diane Shnitzler (703) 691-1805. Interventional Radiology Treatments for Kidney Cancer Interventional Radiology Treatments for Kidney Cancer FACT SHEET Contact Maryann Verrillo Diane Shnitzler (703) 691-1805 Kidney cancer is the eighth most common cancer in men and the tenth in women. 1

More information

Case Log Information for Urology Programs Review Committee for Urology

Case Log Information for Urology Programs Review Committee for Urology Case Log Information for Urology Programs Review Committee for Urology Index Categories, Minimum Numbers, and Common CPT Codes The Committee has reviewed the minimum number of procedures required for resident

More information

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER There is a range of methods available to your healthcare professional to verify the

More information

Us TOO University Presents: Understanding Diagnostic Testing

Us TOO University Presents: Understanding Diagnostic Testing Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by

More information

A Woman s Guide to Prostate Cancer Treatment

A Woman s Guide to Prostate Cancer Treatment A Woman s Guide to Prostate Cancer Treatment Supporting the man in your life Providing prostate cancer support and resources for women and families WOMEN AGAINST PROSTATE CANCER A Woman s Guide to Prostate

More information

PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology

PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology PROSTATE CANCER Get the facts, know your options Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology i What is the Prostate? Unfortunately, you have prostate

More information

Prostate Cancer Guide. A resource to help answer your questions about prostate cancer

Prostate Cancer Guide. A resource to help answer your questions about prostate cancer Prostate Cancer Guide A resource to help answer your questions about prostate cancer Thank you for downloading this guide to prostate cancer treatment. We know that all the information provided online

More information

Radiation Therapy for Prostate Cancer

Radiation Therapy for Prostate Cancer Radiation Therapy for Prostate Cancer Introduction Cancer of the prostate is the most common form of cancer that affects men. About 240,000 American men are diagnosed with prostate cancer every year. Your

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40. A.D.A.M. Medical Encyclopedia. Prostate cancer Cancer - prostate; Biopsy - prostate; Prostate biopsy; Gleason score Last reviewed: October 2, 2013. Prostate cancer is cancer that starts in the prostate

More information

Roswell Park scientists and clinicians:

Roswell Park scientists and clinicians: The Prostate Cancer Center at Roswell Park Connects You to Nationally Recognized Experts for State-of-the-Art Treatment Options and Compassionate, Evidence-based Care Founded in 1898, Roswell Park Cancer

More information

DIAGNOSIS OF PROSTATE CANCER

DIAGNOSIS OF PROSTATE CANCER DIAGNOSIS OF PROSTATE CANCER Determining the presence of prostate cancer generally involves a series of tests and exams. Before starting the testing process, the physician will ask questions about the

More information

Comprehensive Adult & Pediatric Urology

Comprehensive Adult & Pediatric Urology Comprehensive Adult & Pediatric Urology Our Physicians: Philip P. Brodak, Richard Jeffrey Conner, Monisha S. Crisell, Sreenivas Vemulapalli, Tri Valley Urology Medical Group 25495 Medical Center Drive,

More information

An Introduction to PROSTATE CANCER

An Introduction to PROSTATE CANCER An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the

More information

Cancer doesn t care but we do. 2010 Cancer Annual Report

Cancer doesn t care but we do. 2010 Cancer Annual Report Cancer doesn t care but we do. 2010 Cancer Annual Report The Cancer Committee of CHRISTUS St. Patrick Hospital is proud to present its 2010 Annual Report. The Community Hospital Comprehensive Cancer Program

More information

Prostate Cancer In-Depth

Prostate Cancer In-Depth Prostate Cancer In-Depth Introduction Prostate cancer is the most common visceral malignancy among American men. In the year 2003, there are expected to be 220,000 new cases and nearly 29,000 deaths in

More information

Treating Prostate Cancer

Treating Prostate Cancer Treating Prostate Cancer A Guide for Men With Localized Prostate Cancer Most men have time to learn about all the options for treating their prostate cancer. You have time to talk with your family and

More information

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT KEYWORDS: Prostate cancer, PSA, Screening, Radical Prostatectomy LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to:

More information

Renal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology)

Renal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) QUEENSWAY CARLETON HOSPITAL DIVISION OF UROLOGY NEPEAN, ON, CANADA Disclosures None Objectives Advances in the field of Renal Cell

More information

PATIENT GUIDE. Localized Prostate Cancer

PATIENT GUIDE. Localized Prostate Cancer PATIENT GUIDE Localized Prostate Cancer The prostate* is part of the male reproductive system. It is about the same size as a walnut and weighs about an ounce. As pictured in Figure 1, the prostate is

More information

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is

More information

Prostate Cancer & Its Treatment

Prostate Cancer & Its Treatment Your Health Matters Prostate Cancer & Its Treatment By the UCSF Medical Center Prostate Cancer Advocates Greetings! From our personal experience in dealing with our own prostate cancers, we UCSF Patient

More information

Uterine sarcomas are very rare. They are responsible for only 1 to 5 percent of all malignancies

Uterine sarcomas are very rare. They are responsible for only 1 to 5 percent of all malignancies EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas

More information

Minimally Invasive Surgical Treatment of Prostate Cancer: Robots, Microwaves, and Freezers

Minimally Invasive Surgical Treatment of Prostate Cancer: Robots, Microwaves, and Freezers Minimally Invasive Surgical Treatment of Prostate Cancer: Robots, Microwaves, and Freezers Paul D. Maroni, MD Assistant Professor Department of Surgery/Urology Disclosures Relevant EDAP HIFU - investigator

More information

Your Health Matters. Localized Prostate Cancer and Its Treatment

Your Health Matters. Localized Prostate Cancer and Its Treatment Your Health Matters Localized Prostate Cancer and Its Treatment Greetings! Understanding prostate cancer and choosing among the various treatment options can be a difficult and anxiety-arousing process.

More information

NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER

NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER Media Release April 7, 2009 For Immediate Release NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER London, Ontario Improved hybrid imaging techniques developed

More information

Advanced Prostate Cancer Treatments

Advanced Prostate Cancer Treatments Advanced Prostate Cancer Treatments Guest Expert: Kevin, DO Associate Professor of Medical Oncology, Yale Cancer Center www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with

More information

DIEGO M. RUBINOWICZ, MD

DIEGO M. RUBINOWICZ, MD Curriculum Vitae for DIEGO M. RUBINOWICZ, MD Certified Diplomate of the American Board of Urology General Urology Minimally invasive Urology and Laparoscopy UROLOGY CENTER OF PALM BEACH, PA Office address:

More information

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer. Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which

More information

OKLAHOMA PROSTATE CANCER SYMPOSIUM

OKLAHOMA PROSTATE CANCER SYMPOSIUM OKLAHOMA PROSTATE CANCER Saturday, September 26, 2015 Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, OK Earn up to 5.5 AMA PRA Category 1 Credits TM Register online: cme.ouhsc.edu Michael

More information

ROBOTIC ASSISTED RADICAL PROSTATECTOMY

ROBOTIC ASSISTED RADICAL PROSTATECTOMY Associates: Dr Kim Pese Dr Kym Horsell Dr Michael Chong Dr Jason Lee The Tennyson Centre Suite 19, First Floor 520 South Road Kurralta Park SA 5037 Appointments: 08 8292 2399 Fax: 08 8292 2388 admin@urologicalsolutions.com.au

More information

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH). Prostate Cancer Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around

More information

BLADDER HEALTH. Non-Muscle Invasive Bladder Cancer: A Patient Guide

BLADDER HEALTH. Non-Muscle Invasive Bladder Cancer: A Patient Guide BLADDER HEALTH Non-Muscle Invasive Bladder Cancer: A Patient Guide What is the Bladder? What is Cancer? The bladder is a balloon-shaped organ in your pelvic* area that stores urine and is made up of four

More information

Prostate Cancer. Patient Information

Prostate Cancer. Patient Information Prostate Cancer Patient Information 1 The Prostate & Prostate Cancer The prostate is a small gland in the male reproductive system, approximately the size and shape of a walnut. It is located directly

More information

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies

More information

1. What is the prostate-specific antigen (PSA) test?

1. What is the prostate-specific antigen (PSA) test? 1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor

More information

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt

BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader. Two years ago, I was working as a bedside nurse. One of my colleagues felt Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years

More information

Steward Robotics Surgery Services at St. Elizabeth s Medical Center: Quality Outcomes

Steward Robotics Surgery Services at St. Elizabeth s Medical Center: Quality Outcomes Steward Health Forum Steward Robotics Surgery Services at St. Elizabeth s Medical Center: Quality Outcomes Steward Health Care System, LLC Published: June 2013 736 Cambridge Street, Brighton, MA 02135

More information

da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy)

da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy) da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy) Prostate Cancer Overview Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the

More information

Robert Bristow MD PhD FRCPC

Robert Bristow MD PhD FRCPC Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research

More information

State-of-the-art Treatment for Prostate Cancer

State-of-the-art Treatment for Prostate Cancer State-of-the-art Treatment for Prostate Cancer Guest Expert: James, MD Assistant Professor of Therapeutic Radiology at Yale School of Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

Prostate Cancer Screening. A Decision Guide for African Americans

Prostate Cancer Screening. A Decision Guide for African Americans Prostate Cancer Screening A Decision Guide for African Americans This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Published

More information

Precise, Minimally Invasive Prostate Cancer Removal

Precise, Minimally Invasive Prostate Cancer Removal Precise, Minimally Invasive Prostate Cancer Removal Learn why da Vinci Surgery may be your best treatment option 1 Beyond Minimally Invasive For Prostate Cancer 1 Facing Prostate Cancer Prostate cancer

More information

Brian Louis Cohen, M.D., M.P.H.

Brian Louis Cohen, M.D., M.P.H. Brian Louis Cohen, M.D., M.P.H. MEDICAL TRAINING Fellowship in Female Urology, Voiding Dysfunction, and Reconstructive Urology Anticipated, July 2007 June 2008 Residency in Urology, July 2003 June 2007

More information

prostate cancer: A Success Story

prostate cancer: A Success Story prostate cancer: A Success Story Prostate cancer is the most common cancer in human beings. That is, even though prostate cancer occurs only in men, the number of men with prostate cancer exceeds the combined

More information

Prostate Cancer. Understanding your diagnosis

Prostate Cancer. Understanding your diagnosis Prostate Cancer Understanding your diagnosis Prostate Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount

More information

Lectures Hands On Simula on Roundtable Discussions Panel Discussion August 14, 2015

Lectures Hands On Simula on Roundtable Discussions Panel Discussion August 14, 2015 presents Kidney Stones: Medical, Surgical and Dietary Approaches Lectures Hands On Simula on Roundtable Discussions Panel Discussion August 14, 2015 This ac vity has been approved for AMA PRA Category

More information

Correct Coding to Maximize Reimbursements: Common Urological Coding and Billing Errors. Michael A. Ferragamo, MD, FACS

Correct Coding to Maximize Reimbursements: Common Urological Coding and Billing Errors. Michael A. Ferragamo, MD, FACS Correct Coding to Maximize Reimbursements: Common Urological Coding and Billing Errors Michael A. Ferragamo, MD, FACS Coding and Reimbursement Consultant; Assistant Clinical Professor of Urology, University

More information

Radiation Therapy in Prostate Cancer Current Status and New Advances

Radiation Therapy in Prostate Cancer Current Status and New Advances Radiation Therapy in Prostate Cancer Current Status and New Advances Arno J. Mundt MD Professor and Chairman Dept Radiation Oncology Moores Cancer Center UCSD Presentation Welcome Overview of UCSD, Moores

More information

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and

More information

SIGNPOSTS. Along the Pathway of Prostate Cancer. Understanding Diagnostic Tests and Procedures to Monitor Prostate Cancer

SIGNPOSTS. Along the Pathway of Prostate Cancer. Understanding Diagnostic Tests and Procedures to Monitor Prostate Cancer SIGNPOSTS Along the Pathway of Prostate Cancer Understanding Diagnostic Tests and Procedures to Monitor Prostate Cancer Your journey is unique like you. Signposts along the pathway can show you where you

More information

Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone

More information

Therapies for Prostate Cancer and Treatment Selection

Therapies for Prostate Cancer and Treatment Selection Prostatic Diseases Therapies for Prostate Cancer and Treatment Selection JMAJ 47(12): 555 560, 2004 Yoichi ARAI Professor and Chairman, Department of Urology, Tohoku University Graduate School of Medicine

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision

GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision RADIATION THERAPY FOR GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT GYNECOLOGIC CANCERS Gynecologic cancers

More information

male sexual dysfunction

male sexual dysfunction male sexual dysfunction lack of desire Both men and women often lose interest in sex during cancer treatment, at least for a time. At first, concern for survival is so overwhelming that sex is far down

More information

A918: Prostate: adenocarcinoma

A918: Prostate: adenocarcinoma A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)

More information

BLADDER CANCER GLOSSARY OF TERMS

BLADDER CANCER GLOSSARY OF TERMS BLADDER CANCER GLOSSARY OF TERMS Abdomen: The part of the body that contains the pancreas, stomach, intestines, kidneys, urinary bladder, liver, gallbladder, and other organs. Anesthesia: Loss of feeling

More information

P R O S T A T E C A N C E R

P R O S T A T E C A N C E R The Management of Localized P R O S T A T E C A N C E R Patient Guide Based on recommendations from the Prostate Cancer Clinical Guideline Panel of the American Urological Association The AUA Foundation

More information

Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011

Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011 Urology Nurse Practitioner Helen Crowe Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011 Nurse Practitioner Registered nurse who has

More information

innovations Health Services Research: Identifying Gaps Between Standards and Practices pg 4 in Urology

innovations Health Services Research: Identifying Gaps Between Standards and Practices pg 4 in Urology Winter 2013 innovations in Urology Health Services Research: Identifying Gaps Between Standards and Practices pg 4 A survivorship program optimizes post-prostatectomy quality of life pg 3 Surgeon-scientists

More information

THE UROLOGY RESIDENCY PROGRAM OF THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Overview

THE UROLOGY RESIDENCY PROGRAM OF THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Overview THE UROLOGY RESIDENCY PROGRAM OF THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2014 THE UROLOGY RESIDENCY PROGRAM OF THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Overview The Mount Sinai Urology Residency

More information

Prostate Cancer Screening. A Decision Guide

Prostate Cancer Screening. A Decision Guide Prostate Cancer Screening A Decision Guide This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Is screening right for you?

More information

High Intensity Focused Ultrasound for Prostate Cancer

High Intensity Focused Ultrasound for Prostate Cancer High Intensity Focused Ultrasound for Prostate Cancer Patient Information Exploring a Minimally Invasive Prostate Cancer Therapy The Choice for HIFU Worldwide A Patient s Guide to Prostate Cancer and Sonablate

More information

surg urin Surgery: Urinary System 1

surg urin Surgery: Urinary System 1 Surgery: Urinary System 1 This section contains information to assist providers in billing for surgical procedures related to the urinary system. Extracorporeal Shock Wave Lithotripsy Medi-Cal covers Extracorporeal

More information

A912: Kidney, Renal cell carcinoma

A912: Kidney, Renal cell carcinoma A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type

More information

Prostate Cancer Action Plan: Choosing the treatment that s right for you

Prostate Cancer Action Plan: Choosing the treatment that s right for you Prostate Cancer Action Plan: Choosing the treatment that s right for you Segment 1: Introduction Trust me, there's a better way to choose a treatment for your prostate cancer. Watching this program is

More information

Get all the Information about Prostate Cancer Treatment

Get all the Information about Prostate Cancer Treatment Volume Article.13-05 Publish Date: 28 th January 2013 Author(s): MPUH - CRS Team Get all the Information about Prostate Cancer Treatment ARTICLE hhh Muljibhai Patel Urological Hospital (MPUH) Centre For

More information

Understanding Prostate Cancer. The Urology Group Guide for Newly Diagnosed Patients. Advanced Care. Improving Lives.

Understanding Prostate Cancer. The Urology Group Guide for Newly Diagnosed Patients. Advanced Care. Improving Lives. Understanding Prostate Cancer The Urology Group Guide for Newly Diagnosed Patients Advanced Care. Improving Lives. UNDERSTANDING PROSTATE CANCER The Urology Group has created this publication to provide

More information

HEALTH NEWS PROSTATE CANCER THE PROSTATE

HEALTH NEWS PROSTATE CANCER THE PROSTATE HEALTH NEWS PROSTATE CANCER THE PROSTATE Prostate comes from the Greek meaning to stand in front of ; this is very different than prostrate which means to lie down flat. The prostate is a walnut-sized

More information

For further information on screening and early detection of prostate cancer, see the Section entitled Screening for Prostate Cancer.

For further information on screening and early detection of prostate cancer, see the Section entitled Screening for Prostate Cancer. Prostate Cancer For many older men, prostate cancer may be present but never cause symptoms or problems and many men will die with their prostate cancer rather than of their prostate cancer. Yet it remains

More information

Proton Therapy for Prostate Cancer: Your Questions, Our Answers.

Proton Therapy for Prostate Cancer: Your Questions, Our Answers. Proton Therapy for Prostate Cancer: Your Questions, Our Answers. When you re looking for the right treatment for your prostate cancer, nothing s more important than accurate information. Read on, and learn

More information

Information for men considering a male sling procedure

Information for men considering a male sling procedure Information for men considering a male sling procedure Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

X-Plain Prostatectomy Reference Summary

X-Plain Prostatectomy Reference Summary X-Plain Prostatectomy Reference Summary Introduction Prostate cancer is a very common condition that affects men. The rate of occurrence of prostate cancer increases with age. Prostatectomy is a surgery

More information